Clinical Trials

Phase 2 Not yet recruiting

54 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms, Disease Progression

NCT07514455 2026-04-07

RECOMEND

20 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Disease Progression

NCT04205838 2026-02-27

Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma

23 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse, Disease Progression

NCT04954820 2026-02-05

ReLUTH

Phase 2 Not yet recruiting

146 enrolled

EndocrineNET

Neuroendocrine Tumors, Disease Progression

NCT07274384 2025-12-10

HYPERBOLIC

74 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Disease Progression

NCT04974671 2025-12-04

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

30 enrolled

Genitourinary

Carcinoma, Renal Cell, Disease Progression

NCT03990571 2024-10-18

Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

40 enrolled 13 charts

Carcinoma, Adenoid Cystic, Disease Progression

NCT06472388 2024-06-25

EVENET

Phase 2 Active not recruiting

100 enrolled

EndocrineNET

Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors, Disease Progression

NCT03374332 2024-02-08

Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

11 enrolled

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Disease Progression

NCT04149821 2023-06-15

Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy

LymphoidOther hematologic neoplasm

1 enrolled 8 charts

Leukemia, Lymphocytic, Chronic, B-Cell, Disease Progression

NCT03727841 2022-07-27

Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma

4 enrolled 13 charts

Ependymoma, Disease Progression

NCT04033432 2022-04-27

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

14 enrolled 13 charts

Genitourinary

Prostatic Neoplasms, Disease Progression

NCT04905056 2021-05-27

A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules

120 enrolled

Disease Progression

NCT02715297 2020-03-10

GlioCave/NOA17

162 enrolled

BreastGenitourinaryThoracic

Glioblastoma, Disease Progression

NCT02538432 2019-11-04

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

Phase 2 Withdrawn

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Disease Progression

NCT03469804 2019-10-21

KAPKEY

17 enrolled

Sarcoma

Sarcoma, Kaposi, Disease Progression

NCT01737450 2019-06-24

PIK-ORL

58 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence, Disease Progression

NCT03804866 2019-01-15

NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)

14 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Disease Progression

NCT03601624 2018-11-14

MM-POM-2018

18 enrolled

Plasma cell

Multiple Myeloma, Recurrence, Disease Progression

NCT01358071 2018-09-27

NGR018

119 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Disease Progression

NCT01110668 2017-02-28

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

2 enrolled

GastrointestinalSarcoma

Disease Progression, Gastrointestinal Stromal Tumors

NCT00995007 2016-03-29

A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

112 enrolled 12 charts

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma, Disease Progression

NCT00108069 2015-11-05

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

43 enrolled 11 charts

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

NCT01778530 2015-10-07

TRC105 for Recurrent Glioblastoma

2 enrolled 9 charts

Glioblastoma, Glioma, Disease Progression

NCT00908232 2015-01-15

SEQUENTIAL

163 enrolled 11 charts

Plasma cell

Multiple Myeloma, Disease Progression, Bone Marrow Neoplasms

NCT00393094 2012-07-13

Bevacizumab and Irinotecan to Treat Brain Tumors

31 enrolled 12 charts

Brain Neoplasms, Glioma, Disease Progression

NCT00530140 2011-10-06

FLIDVAX2006

100 enrolled

Lymphoid

Lymphoma, Follicular, Disease Progression

NCT00517621 2011-02-25

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire